Increased serum levels of syndecan-1 and HA are known to be elevated in the acute phase of Kawasaki patients, and serum HA predicts future coronary artery lesion development, possibly implicating that similar mechanisms could occur in COVID-19 (79). The gene discussed is SDC1; the disease is medical procedure.